Researchers track how support programs affect lives of lung disease patients
NCT ID NCT06912659
Summary
This study aims to understand how satisfied patients are with a special support program and how it affects their quality of life. It will follow 157 adults in Spain who have pulmonary fibrosis and are already taking the medication nintedanib. Researchers will track their experiences, symptoms, and medication use over 12 months to see if the support program helps.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY FIBROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Evidenze Health Espana S.L.
Barcelona, 08005, Spain
Conditions
Explore the condition pages connected to this study.